ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules.

Margaret E Gatti-Mays et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.